Literature DB >> 10785372

Characterization of the myo-inositol transport system in Trypanosoma cruzi.

M Einicker-Lamas1, A C Almeida, A G Todorov, S L de Castro, C Caruso-Neves, M M Oliveira.   

Abstract

myo-inositol is a growth factor for mammalian cells as well as for the pathogenic protozoa Trypanosoma cruzi. Most of the cell surface molecules in this organism rely on myo-inositol as the biosynthetic precursor for phosphoinositides and glycosylated phosphatidylinositols. The aim of this work was to investigate the process of myo-inositol translocation across the parasite cell membrane. myo-Inositol uptake was concentration-dependent in the concentration range 0.1-10 microM with maximal transport obtained at 8 microM. Using sodium-free buffers, where Na+ was replaced by choline or K+, myo-inositol uptake was inhibited by 50%. Furosemide, an inhibitor of the ouabain-insensitive Na+-ATPase, inhibited the Na+-dependent and Na+-independent myo-inositol uptake by 68 and 33%, respectively. In contrast, ouabain, an (Na++/K+) ATPase inhibitor, did not affect transport. Part of the myo-inositol uptake is mediated by active transport as it was inhibited when energy metabolism inhibitors such as carbonyl cyanide p-(trifluoromethoxy)-phenylhydrazone (34%), 2,4-dinitrophenol (50%), KCN (71%) and NaN3 (69%) were added to the medium, or the temperature of the medium was lowered to 4 degrees C. The addition of glucose (5-50 mM) or mannose (10 mM) did not change the myo-inositol uptake, whereas the addition of 10 mM nonlabeled myo-inositol totally inhibited this transport, indicating that the transporter is specific for myo-inositol. Phloretin (0.3 mM) and phoridzin (5 mM), but not cytochalasin B, were efficient inhibitors of myo-inositol uptake. A portion of the accumulated myo-inositol is converted to inositol phosphates and phosphoinositides. These data show that myo-inositol transport in T. cruzi epimastigotes is mediated by at least two specific transporters - one Na+-dependent and the other Na+-independent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785372     DOI: 10.1046/j.1432-1327.2000.01302.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Lipid metabolism in Trypanosoma brucei.

Authors:  Terry K Smith; Peter Bütikofer
Journal:  Mol Biochem Parasitol       Date:  2010-04-09       Impact factor: 1.759

Review 2.  Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans.

Authors:  Srinivasan Ramakrishnan; Mauro Serricchio; Boris Striepen; Peter Bütikofer
Journal:  Prog Lipid Res       Date:  2013-07-01       Impact factor: 16.195

3.  Trypanosoma brucei Bloodstream Forms Depend upon Uptake of myo-Inositol for Golgi Complex Phosphatidylinositol Synthesis and Normal Cell Growth.

Authors:  Amaia González-Salgado; Michael Steinmann; Louise L Major; Erwin Sigel; Jean-Louis Reymond; Terry K Smith; Peter Bütikofer
Journal:  Eukaryot Cell       Date:  2015-04-17

4.  myo-Inositol uptake is essential for bulk inositol phospholipid but not glycosylphosphatidylinositol synthesis in Trypanosoma brucei.

Authors:  Amaia Gonzalez-Salgado; Michael E Steinmann; Eva Greganova; Monika Rauch; Pascal Mäser; Erwin Sigel; Peter Bütikofer
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

5.  Phosphatidylinositol synthesis, its selective salvage, and inter-regulation of anionic phospholipids in Toxoplasma gondii.

Authors:  Bingjian Ren; Pengfei Kong; Fatima Hedar; Jos F Brouwers; Nishith Gupta
Journal:  Commun Biol       Date:  2020-12-10

Review 6.  Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it.

Authors:  Todd B Reynolds
Journal:  Microbiology (Reading)       Date:  2009-04-21       Impact factor: 2.777

7.  Functional Characterization of Pneumocystis carinii Inositol Transporter 1.

Authors:  Melanie T Cushion; Margaret S Collins; Thomas Sesterhenn; Aleksey Porollo; Anish Kizhakkekkara Vadukoot; Edward J Merino
Journal:  MBio       Date:  2016-12-13       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.